| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| RARbeta ligand binding domain bound to an SRC 1 co activator peptide : purification , crystallization and preliminary 10 ray diffraction analysis . ^^^ Here , a strategy used to express a large scale soluble fraction of the human RARbeta LBD suitable for biophysical analysis is reported , as well as a procedure for crystallizing it bound to a synthetic retinoid ( TTNPB ) with or without a co activator peptide ( SRC 1 ) . ^^^ |
|
| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| The aim of the study was to test the hypothesis that expression of retinoid receptors ( RARalpha , RARbeta , RARgamma ) , rexinoid receptors ( RXRalpha , RXRbeta ) , thyroid hormone receptors ( TRalpha , TRbeta ) , estrogen receptors ( ERalpha , ERbeta ) , nuclear receptor coregulators ( N CoR , SRC 1 , SMRT ) , and in addition type 1 iodothyronine 5 ' deiodinase ( 5 ' DI ) , EGFR and erb B2 / neu would be different in mammary postlactating tissue in comparison with that of nonlactating mammary gland . ^^^ |
|
| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10826 and Q15788 |
Pubmed |
SVM Score :0.0 |
| NA |
|